Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors-Reference-Cited by-同舟云学术

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

Published:2022-04-25 Issue:4 Volume:3 Page:418-436
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Herpers Bram,Eppink Berina,James Mark I.,Cortina Carme,Cañellas-Socias Adrià,Boj Sylvia F.,Hernando-Momblona Xavier,Glodzik Dominik,Roovers Rob C.,van de Wetering Marc,Bartelink-Clements Carina,Zondag-van der Zande Vanessa,Mateos Jara García,Yan Kuan,Salinaro Lucia,Basmeleh Abdul,Fatrai Szabolcs,Maussang David,Lammerts van Bueren Jeroen J.,Chicote Irene,Serna Garazi^ORCID,Cabellos Laia,Ramírez Lorena,Nuciforo Paolo^ORCID,Salazar Ramon,Santos Cristina^ORCID,Villanueva Alberto^ORCID,Stephan-Otto Attolini Camille^ORCID,Sancho Elena^ORCID,Palmer Hector G.,Tabernero Josep^ORCID,Stratton Michael R.^ORCID,de Kruif John,Logtenberg Ton,Clevers Hans^ORCID,Price Leo S.,Vries Robert G. J.,Batlle Eduard^ORCID,Throsby Mark^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-022-00359-0.pdf

Reference69 articles.

1. Merlos-Suárez, A. et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell https://doi.org/10.1016/j.stem.2011.02.020 (2011).

2. Vermeulen, L. et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl Acad. Sci. USA 105, 13427–13432 (2008).

3. de Sousa e Melo, F. et al. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature 543, 676–680 (2017).

4. Schepers, A. G. et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730–735 (2012).

5. Cortina, C. et al. A genome editing approach to study cancer stem cells in human tumors. EMBO Mol. Med. 9, 869–879 (2017).

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug evaluation platform based on non-destructive and real-time in situ organoid fate state monitoring by graphene field-effect transistor;Chemical Engineering Journal;2024-10

2. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids;Journal of Experimental & Clinical Cancer Research;2024-09-11

3. Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement;Biochemical Pharmacology;2024-09

4. Global Scientific Trends in Organoids from 2004 to 2023: A Data-Driven Bibliometric and Visualized Analysis;2024-08-28

5. Novel immunotherapeutics against LGR5 to target multiple cancer types;EMBO Molecular Medicine;2024-08-21